Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
634.07
-26.93 (-4.07%)
At close: Mar 25, 2025, 4:00 PM
633.03
-1.04 (-0.16%)
After-hours: Mar 25, 2025, 5:39 PM EST
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
25
Consensus Rating
Buy
Price Target
$990.84
Upside
+56.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Maintains $940 → $759 | Hold | Maintains | $940 → $759 | +19.70% | Feb 5, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $762 → $834 | Hold → Buy | Upgrades | $762 → $834 | +31.53% | Feb 5, 2025 |
| Citigroup | Citigroup | Hold Maintains $795 → $750 | Hold | Maintains | $795 → $750 | +18.28% | Jan 28, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,195 → $1,013 | Buy | Maintains | $1,195 → $1,013 | +59.76% | Jan 27, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $1,130 → $738 | Strong Buy → Hold | Downgrades | $1,130 → $738 | +16.39% | Jan 16, 2025 |
| Citigroup | Citigroup | Hold Maintains $895 → $795 | Hold | Maintains | $895 → $795 | +25.38% | Jan 14, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $1,050 → $900 | Buy | Maintains | $1,050 → $900 | +41.94% | Jan 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $1,126 → $1,004 | Strong Buy | Maintains | $1,126 → $1,004 | +58.34% | Jan 8, 2025 |
| Bernstein | Bernstein | Buy Maintains $1,110 → $1,070 | Buy | Maintains | $1,110 → $1,070 | +68.75% | Jan 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Initiates $165 | Hold | Initiates | $165 | -73.98% | Dec 17, 2024 |
| B of A Securities | B of A Securities | Sell Initiates $565 | Sell | Initiates | $565 | -10.89% | Dec 10, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates $1,150 | Buy | Initiates | $1,150 | +81.37% | Nov 15, 2024 |
| Citigroup | Citigroup | Hold Initiates $895 | Hold | Initiates | $895 | +41.15% | Nov 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $1,150 → $1,000 | Buy | Maintains | $1,150 → $1,000 | +57.71% | Nov 6, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $1,235 → $1,184 | Buy | Maintains | $1,235 → $1,184 | +86.73% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $1,260 → $1,215 | Buy | Maintains | $1,260 → $1,215 | +91.62% | Nov 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.